Immorta Bio, Inc.

Biotechnology company · Miami Beach, Florida, United States

Immorta Bio, Inc. is a biotechnology company headquartered in Miami Beach, Florida, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $450,000 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Immorta Bio at a glance

Typebiotechnology company

HeadquartersMiami Beach, Florida, United States

Earliest incorporation on record2023

SEC CIK2102665

What does Immorta Bio do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $450,000 sold (2026).

Frequently asked questions about Immorta Bio

Where is Immorta Bio headquartered?

Immorta Bio, Inc. is headquartered in Miami Beach, Florida, United States.

What does Immorta Bio do?

Immorta Bio, Inc. is a biotechnology company.

When was Immorta Bio founded?

The earliest incorporation on record for Immorta Bio, Inc. is in 2023, according to public company registers.

Similar companies

SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Genetic Networks, LLCMiami Beach, Florida, United States
Relation Therapeutics Inc.Miami Beach, Florida, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences